신약개발 분야 정부 R&D 현황과 효율성 제고 방안

Summary

South Korea's pharmaceutical industry lags behind major countries in global new drug development, facing high risks and costs in R&D, necessitating improved government investment efficiency. The proposed approach focuses on strategic R&D investment at each development stage, fostering an ecosystem for SMEs, and providing customized support based on private investor perspectives. The average efficiency of government R&D investment in new drug development is increasing, with specific programs like the Korea Drug Development Fund exceeding goals for global technology transfers and fees.

Key Facts

Source Document

https://example-government.gov/policy-document-link